Prostate Cancer in Bone: Importance of Context for Inhibition of Matrix Metalloproteinases
- 2 January 2002
- journal article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 94 (1) , 4-5
- https://doi.org/10.1093/jnci/94.1.4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Metastatic patterns of prostate cancer: An autopsy study of 1,589 patientsHuman Pathology, 2000
- Expression and Prognostic Significance of Metalloproteinases and Their Tissue Inhibitors in Patients With Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.1999
- An odyssey from breast to bone: Multi‐step control of mammary metastases and osteolysis by matrix metalloproteinasesAPMIS, 1999
- Fibronectin and Its Integrin Receptors in CancerPublished by Elsevier ,1999
- Matrix Metalloproteinase Stromelysin-1 Triggers a Cascade of Molecular Alterations That Leads to Stable Epithelial-to-Mesenchymal Conversion and a Premalignant Phenotype in Mammary Epithelial CellsThe Journal of cell biology, 1997
- Mechanisms of bone metastasisCancer, 1997
- Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.Journal of Clinical Investigation, 1997
- Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.1995
- Why do cancer cells metastasize into particular organs?BioEssays, 1992